Physician profile
Collin Daniel Smith
NPI 1932606464
$774.98
in general payments reported to CMS, 2019-2025
13 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.50 · 2022: $195 · 2023: $192 · 2024: $51.65 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $190.07 | 2022-2023 | Scopis Ent |
| Inspire Medical Systems, INC. | $142.64 | 2023-2025 | Inspire |
| Medtronic, INC. | $122.42 | 2022 | |
| Medtronic USA, INC. | $64.50 | 2019 | |
| Cochlear Americas | $48.61 | 2024-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Organogenesis INC. | $43.80 | 2025 | Apligraf |
| Glaxosmithkline, LLC. | $33.26 | 2025 | Nucala |
| Ethicon US, LLC | $29.42 | 2025 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Jazz Pharmaceuticals INC. | $26.15 | 2025 | |
| Genzyme Corporation | $25.18 | 2025 | |
| Genentech USA, INC. | $18.96 | 2025 | Xolair |
| Avadel Cns Pharmaceuticals, LLC | $15.70 | 2025 | Lumryz |
| Advanced Bionics, LLC | $14.27 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.